Study of safety of CSJ117 in participants with moderate to severe uncontrolled asthma
Phase 2
- Conditions
- Asthma
- Registration Number
- JPRN-jRCT2031210301
- Lead Sponsor
- Yamada Hiroyuki
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
1. Participants completing the Treatment period of prior study and continuing with this study must have completed the Treatment period of prior study.
2. Participants completing the Treatment period and Follow-up period of prior study and continuing with this study must have completed the Treatment period of prior study and Follow-up period of the core study.
Exclusion Criteria
1. Participants prematurely discontinued irrespective of the reason from the prior study.
2. Participants who were enrolled into prior study and developed a significant and/or permanent health condition during the prior study that would have excluded them from participation in that study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method umber of treatment emergent adverse events (AEs) and serious adverse events (SAEs)
- Secondary Outcome Measures
Name Time Method